Business Description

Abeona Therapeutics is focused on developing and delivering gene therapy products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company's close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases such as Epidermolysis Bullosa, Sanfilippo syndrome, Batten disease, and other rare disorders.

Company Info

Address:
1330 Avenue of the Americas
33rd Floor
New York, NY 10019

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

NAICS:
In-Vitro Diagnostic Substance Manufacturing (325413)

SIC:
Pharmaceutical Preparations (2834)